Insulin-like growth factor-I prevents caspase-mediated apoptosis in Schwann cells.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Neurobiology

• Publication date

  1999-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-4695(199912)41:4<540::AID-NEU9>3.0.CO;2-PPMID 10590177
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Mitochondria and apoptosis].

  2000cited by this paper
• GTPases and phosphatidylinositol 3-kinase are critical for insulin-like growth factor-I-mediated Schwann cell motility.

  2000cited by this paper
• A Role for Insulin-Like Growth Factor-I in the Regulation of Schwann Cell Survival

  1999cited by this paper
• Bidirectional Regulation of p38 Kinase and c-Jun N-terminal Protein Kinase by Insulin-like Growth Factor-I*

  1998cited by this paper
• Mitochondria and apoptosis.

  1998cited by this paper
• Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal.

  1998cited by this paper
• Differential Regulation of Focal Adhesion Kinase and Mitogen‐Activated Protein Kinase Tyrosine Phosphorylation During Insulin‐Like Growth Factor‐I‐Mediated Cytoskeletal Reorganization

  1998cited by this paper
• Roles of Bcl-2 and caspases in hypoxia-induced neuronal cell death: a possible neuroprotective mechanism of peptide growth factors.

  1998cited by this paper
• Insulin Receptor Substrate 2 And Shc Play Different Roles In Insulin-like Growth Factor I Signaling*

  1998cited by this paper
• The Bcl-2 protein family: arbiters of cell survival.

  1998cited by this paper
• A matter of life and cell death.

  1998cited by this paper
• TNF‐α and TGF‐β act synergistically to kill Schwann cells

  1998cited by this paper
• Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I.

  1998cited by this paper
• Fate of Schwann Cells in CMT1A and HNPP: Evidence for Apoptosis

  1998cited by this paper
• Caspases: enemies within.

  1998influential reference
• Akt-Dependent and -Independent Survival Signaling Pathways Utilized by Insulin-Like Growth Factor I

  1998cited by this paper
• Insulin-like growth factor I modulates induction of apoptotic signaling in H9C2 cardiac muscle cells.

  1998cited by this paper
• Death receptors: signaling and modulation.

  1998cited by this paper
• Death‐signalling cascade in mouse cerebellar granule neurons

  1998cited by this paper
• Ethanol Induces Apoptosis in Cerebellar Granule Neurons by Inhibiting Insulin‐Like Growth Factor 1 Signaling

  1998cited by this paper
• Insulin-like growth factor-I analogue prevents apoptosis mediated through an interleukin-1 beta converting enzyme (caspase-1)-like protease of cerebellar external granular layer neurons: developmental stage-specific mechanisms of neuronal cell death.

  1998cited by this paper
• Tyrosine phosphorylation of paxillin and focal adhesion kinase by activation of muscarinic m3 receptors is dependent on integrin engagement by the extracellular matrix.

  1998cited by this paper
• Regulation of Schwann cell numbers in tellurium-induced neuropathy: apoptosis, supernumerary cells and internodal shortening

  1998cited by this paper
• Neuregulins as Potential Neuroprotective Agents

  1997cited by this paper
• Glial Growth Factor Rescues Schwann Cells of Mechanoreceptors from Denervation-Induced Apoptosis

  1997cited by this paper
• Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB

  1997cited by this paper
• Insulin-like growth factor-I is an osmoprotectant in human neuroblastoma cells.

  1997cited by this paper
• Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt

  1997cited by this paper
• Insulin-like growth factors regulate neuronal differentiation and survival.

  1997influential reference
• Apoptosis Regulates the Number of Schwann Cells at the Premyelinating Stage

  1997cited by this paper
• Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

  1997cited by this paper
• Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt

  1997cited by this paper
• Expression of Neuregulins and their Putative Receptors, ErbB2 and ErbB3, Is Induced during Wallerian Degeneration

  1997cited by this paper
• Reactive astrocytes: cellular and molecular cues to biological function.

  1997cited by this paper
• Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt.

  1997cited by this paper
• Characterization of CPP32‐Like Protease Activity Following Apoptotic Challenge in SH‐SY5Y Neuroblastoma Cells

  1997cited by this paper
• Basic fibroblast growth factor prevents cAMP‐induced apoptosis in cultured Schwann cells

  1997cited by this paper
• The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.

  1997cited by this paper
• Insulin-like Growth Factor-I-mediated Neurite Outgrowth in Vitro Requires Mitogen-activated Protein Kinase Activation*

  1997cited by this paper
• Insulin-like Growth Factors as Regulators of Cell Motility Signaling Mechanisms.

  1997cited by this paper
• Tyrosine Phosphorylation of Paxillin and Focal Adhesion Kinase during Insulin-like Growth Factor-I-stimulated Lamellipodial Advance*

  1997cited by this paper
• Axon–Schwann cell interactions during peripheral nerve degeneration and regeneration

  1997cited by this paper
• Schwann cell apoptosis at developing neuromuscular junctions is regulated by glial growth factor

  1996cited by this paper
• Cell death in the Schwann cell lineage and its regulation by neuregulin.

  1996cited by this paper
• Growth factor-dependent survival of rodent fibroblasts requires phosphatidylinositol 3-kinase but is independent of pp70S6K activity.

  1996cited by this paper
• Characterization of Insulin‐Like Growth Factor‐I and Its Receptor and Binding Proteins in Transected Nerves and Cultured Schwann Cells

  1996cited by this paper
• Insulin‐like growth factor I rescues SH‐SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death

  1996cited by this paper
• Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor.

  1996cited by this paper
• Axonal Interactions Regulate Schwann Cell Apoptosis in Developing Peripheral Nerve: Neuregulin Receptors and the Role of Neuregulins

  1996influential reference
• Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice

  1996cited by this paper
• Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis.

  1996cited by this paper
• Glial Growth Factor 2, a Soluble Neuregulin, Directly Increases Schwann Cell Motility and Indirectly Promotes Neurite Outgrowth

  1996cited by this paper
• Schwann cell differentiation.

  1996cited by this paper
• The role of the insulin-like growth factors in the central nervous system

  1996cited by this paper
• Glial cell development

  1996cited by this paper
• Regulation of Rat Schwann Cell Po Expression and DNA Synthesis by Insulin‐like Growth Factors In Vitro

  1996cited by this paper
• Type I Insulin-like Growth Factor Receptor Activation Regulates Apoptotic Proteins*

  1996influential reference
• Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor.

  1995cited by this paper
• Fibroblast Growth Factors and Insulin Growth Factors Combine to Promote Survival of Rat Schwann Cell Precursors Without Induction of DNA Synthesis

  1995cited by this paper
• Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF

  1995cited by this paper
• Evidence for large-scale astrocyte death in the developing cerebellum

  1995cited by this paper
• Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors.

  1995cited by this paper
• Insulin-like growth factor-II as a paracrine growth factor in human neuroblastoma cells.

  1995cited by this paper
• Neurones and glial cells of the mouse sciatic nerve undergo apoptosis after injury in vivo and in vitro

  1995cited by this paper
• Multi-step chromatin degradation in apoptosis. DNA breakdown in apoptosis.

  1994cited by this paper
• The Schwann cell precursor and its fate: a study of cell death and differentiation during gliogenesis in rat embryonic nerves.

  1994influential reference
• The Insulin-Like Growth Factor-I Receptor

  1994cited by this paper
• Multi-Step Chromatin Degradation in Apoptosis

  1994cited by this paper
• Induction of apoptosis by transforming growth factor beta 1 in glioma and trigeminal neurinoma cells.

  1994cited by this paper
• Methods for the detection of apoptosis.

  1994cited by this paper
• The insulin-like growth factor-I receptor. Structure, ligand-binding mechanism and signal transduction.

  1994cited by this paper
• Expression of platelet-derived growth factor (PDGF) and PDGF alpha- and beta-receptors in the peripheral nervous system: an analysis of sciatic nerve and dorsal root ganglia.

  1993cited by this paper
• Expression of Platelet-Derived Growth Factor (PDGF) and PDGF α- and β-Receptors in the Peripheral Nervous System: An Analysis of Sciatic Nerve and Dorsal Root Ganglia

  1993cited by this paper
• Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system

  1993cited by this paper
• Cell death in the oligodendrocyte lineage.

  1992cited by this paper
• Cell death during development of the nervous system.

  1991cited by this paper
• Radioautographic evidence for slow astrocyte turnover and modest oligodendrocyte production in the corpus callosum of adult mice infused with 3H‐thymidine

  1988cited by this paper
• PROLIFERATION AND CELL CYCLE PARAMETERS OF ASTROCYTES

  1986cited by this paper
• Studies on cultured rat Schwann cells. III. Assays for peripheral myelin proteins

  1980cited by this paper

• Diabetic peripheral neuropathy based on Schwann cell injury: mechanisms of cell death regulation and therapeutic perspectives

  2024cites this paper
• Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma.

  2023cites this paper
• Intratympanic Insulin-like Growth Factor-1 Administration Via the Otic Bulla in a Severe Facial Paralysis Model

  2021cites this paper
• Dynamics of biomarkers across the stages of traumatic spinal cord injury - implications for neural plasticity and repair

  2021cites this paper
• Japanese Clinical Practice Guideline for Diabetes 2019

  2020cites this paper
• Glycosylated hemoglobin A1c predicts coronary artery disease in non‐diabetic patients

  2020cites this paper
• Managing the multifaceted nature of type 2 diabetes using once‐weekly injectable GLP‐1 receptor agonist therapy

  2020cites this paper
• Cardiovascular safety outcomes of once‐weekly GLP‐1 receptor agonists in people with type 2 diabetes

  2020cites this paper
• Socio‐economic status and mortality in people with type 1 diabetes in Scotland 2006–2015: a retrospective cohort study

  2020cites this paper
• Are newer insulin analogues better for people with Type 1 diabetes?

  2020cites this paper
• Glyco‐metabolic control, inflammation markers, and cardiovascular outcomes in type 1 and type 2 diabetic patients on insulin pump or multiple daily injection (italico study)

  2020cites this paper
• Diabetes drugs and stroke risk: Intensive versus conventional glucose‐lowering strategies, and implications of recent cardiovascular outcome trials

  2020cites this paper
• How tightly controlled do fluctuations in blood glucose levels need to be to reduce the risk of developing complications in people with Type 1 diabetes?

  2020cites this paper
• Serum pro‐inflammatory factors as predictors of persistent diabetic macular oedema with limited anatomic response to anti‐VEGF: association with intravitreal injection treatment profiles in real‐world setting

  2019cites this paper
• Beyond HbA1c: using continuous glucose monitoring metrics to enhance interpretation of treatment effect and improve clinical decision‐making

  2019cites this paper
• Treatment‐induced neuropathy of diabetes: a call for acknowledgement

  2019cites this paper
• The effect of DAFNE education, continuous subcutaneous insulin infusion, or both in a population with type 1 diabetes in Scotland

  2019cites this paper
• Incidence and severity of hypoglycaemia in type 2 diabetes by treatment regimen: A UK multisite 12‐month prospective observational study

  2019cites this paper
• Long‐term (52‐week) efficacy and safety of ipragliflozin add‐on therapy to insulin in Japanese patients with type 1 diabetes mellitus: An uncontrolled, open‐label extension of a phase III study

  2019cites this paper
• Associations of dietary macronutrient and fibre intake with glycaemia in individuals with Type 1 diabetes

  2018cites this paper
• Insulin inhibits the JNK mediated cell death via upregulation of AKT expression in Schwann cells grown in hyperglycemia

  2018cites this paper
• Critical role of the cAMP‐PKA pathway in hyperglycemia‐induced epigenetic activation of fibrogenic program in the kidney

  2017cites this paper
• Alpinia oxyphylla Miq. fruit extract activates IGFR-PI3K/Akt signaling to induce Schwann cell proliferation and sciatic nerve regeneration

  2017cites this paper
• Abnormal response of distal Schwann cells to denervation in a mouse model of motor neuron disease.

  2016cites this paper
• Human Cortical Neural Stem Cells Expressing Insulin-Like Growth Factor-I: A Novel Cellular Therapy for Alzheimer’s Disease

  2016cites this paper
• Involvement of IGF-2, IGF-1R, IGF-2R and PTEN in development of human tooth germ – an immunohistochemical study

  2016cites this paper
• Analysis of expression patterns of IGF-1, caspase-3 and HSP-70 in developing human tooth germs.

  2015cites this paper
• Nerve Regeneration Potential of Protocatechuic Acid in RSC96 Schwann Cells by Induction of Cellular Proliferation and Migration through IGF-IR-PI3K-Akt Signaling.

  2015cites this paper
• Effects of cerebrolysin on rat Schwann cells in vitro.

  2014cites this paper
• Astrocyte-Specific Overexpression of Insulin-Like Growth Factor-1 Protects Hippocampal Neurons and Reduces Behavioral Deficits following Traumatic Brain Injury in Mice

  2013cites this paper
• Evaluation of insulin-like growth factor-1 as a therapeutic approach for the treatment of traumatic brain injury

  2013cites this paper
• Treat-to-target trials: uses, interpretation and review of concepts

  2013cites this paper
• The hepatic response to thermal injury

  2012cites this paper
• Dilong: Role in Peripheral Nerve Regeneration

  2011cites this paper
• Peripheral nervous system topics

  2011cites this paper
• RSC96 Schwann Cell Proliferation and Survival Induced by Dilong through PI3K/Akt Signaling Mediated by IGF-I

  2011cites this paper
• IGF Receptors in the Adult Brain

  2010cites this paper
• Mycobacterium leprae induces insulin‐like growth factor and promotes survival of Schwann cells upon serum withdrawal

  2010influential citation
• Dose adjustment for normal eating (DAFNE) — an audit of outcomes in Australia

  2010cites this paper
• The Pleotrophic Effects of Insulin-Like Growth Factor-I on Human Spinal Cord Neural Progenitor Cells

  2010cites this paper
• elayed nerve repair increases number of caspase 3 stained Schwann cells

  2009cites this paper
• Schwann cell-derived factors support serotoninergic neuron survival and promote neurite outgrowth.

  2009cites this paper
• MMP‐9 controls Schwann cell proliferation and phenotypic remodeling via IGF‐1 and ErbB receptor‐mediated activation of MEK/ERK pathway

  2009cites this paper
• Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptide

  2008cites this paper
• Diabetic neuropathies: components of etiology

  2008cites this paper
• Insulin-like growth factors in the peripheral nervous system.

  2008cites this paper
• Minireview: Insulin-Like Growth Factors in the Peripheral Nervous System

  2008cites this paper
• Chapter 26 – The hepatic response to a thermal injury

  2007cites this paper
• Nidogen is a prosurvival and promigratory factor for adult Schwann cells

  2007cites this paper
• Insulin-like growth factor receptor 1b is required for zebrafish primordial germ cell migration and survival.

  2007cites this paper
• The use of bioluminescence resonance energy transfer for the study of therapeutic targets: application to tyrosine kinase receptors

  2007cites this paper
• PKB/Akt inhibits ceramide‐induced apoptosis in neuroblastoma cells by blocking apoptosis‐inducing factor (AIF) translocation

  2007cites this paper
• Early necrosis and apoptosis of Schwann cells transplanted into the injured rat spinal cord

  2007cites this paper
• IGF-I inhibition of apoptosis is associated with decreased expression of prostate apoptosis response-4.

  2007cites this paper
• Insulin-like growth factor type I biology and targeting in malignant gliomas.

  2007cites this paper
• Secretory products of central nervous system glial cells induce Schwann cell proliferation and protect from cytokine‐mediated death

  2006cites this paper
• Differential gene expression between human schwannoma and control Schwann cells

  2006cites this paper
• IGF-I mediated survival pathways in normal and malignant cells.

  2006cites this paper
• Aspects of Growth Hormone and Insulin-Like Growth Factor-I Related to Neuroprotection, Regeneration, and Functional Plasticity in the Adult Brain

  2006cites this paper
• Oxidative Injury in Diabetic Neuropathy

  2005cites this paper
• Inhibition of Src-like Kinases Reveals Akt-dependent and -independent Pathways in Insulin-like Growth Factor I-mediated Oligodendrocyte Progenitor Survival*

  2005cites this paper
• Consensus statement on diabetes control in preparation for pregnancy

  2005cites this paper
• Regulation of vertebrate sensory organ development: a scenario for growth hormone and insulin-like growth factors action.

  2005cites this paper
• Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters Akt/glycogen synthase kinase-3beta phosphorylation.

  2005cites this paper
• Insulin-like growth factor-I induces the phosphorylation and nuclear exclusion of forkhead transcription factors in human neuroblastoma cells

  2005cites this paper
• c‐Kit receptor expression in normal human Schwann cells and Schwann cell lines derived from neurofibromatosis type 1 tumors

  2005cites this paper
• Insulin-like growth factors in the treatment of neurological disease.

  2005cites this paper
• Schwann cell lines derived from malignant peripheral nerve sheath tumors respond abnormally to platelet‐derived growth factor‐BB

  2005cites this paper
• IGF‐I neuroprotection in the immature brain after hypoxia‐ischemia, involvement of Akt and GSK3β?

  2005cites this paper
• Growth Hormone-Releasing Peptide Hexarelin Reduces Neonatal Brain Injury and Alters Akt/Glycogen Synthase Kinase-3β Phosphorylation

  2005cites this paper
• Chapter 16 – Molecular Signaling in Schwann Cell Development

  2005cites this paper
• Altered Neurotrophism in Diabetic Neuropathy: Spelunking the Caves of Peripheral Nerve

  2005cites this paper
• Effect of growth factors as therapeutic drugs on hepatic metabolism during the systemic inflammatory response syndrome.

  2004cites this paper
• Schwann cell development

  2004cites this paper
• Regulation of tumor necrosis factor-alpha induced apoptosis via posttranslational modifications in a human colon adenocarcinoma cell line

  2004cites this paper
• The trunk neural crest and its early glial derivatives: a study of survival responses, developmental schedules and autocrine mechanisms.

  2004influential citation
• TDAG51 Mediates the Effects of Insulin-like Growth Factor I (IGF-I) on Cell Survival*

  2004cites this paper
• Protection against glucose‐induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3

  2004cites this paper
• Nitrosative Injury and Antioxidant Therapy in the Management of Diabetic Neuropathy

  2004cites this paper
• Cell signals transduced by complement.

  2004cites this paper
• Insulin-like growth factor-I and the cytokines IL-3 and IL-4 promote survival of progenitor myeloid cells by different mechanisms.

  2003cites this paper
• Inhibition of p38 mitogen-activated protein kinase interferes with cell shape changes and gene expression associated with Schwann cell myelination.

  2003cites this paper
• Insulin-like growth factor-1 and post-ischemic brain injury.

  2003cites this paper
• Cell death in the nervous system

  2003cites this paper
• Degradation and dephosphorylation of focal adhesion kinase during okadaic acid-induced apoptosis in human neuroblastoma cells.

  2003cites this paper
• Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells.

  2003cites this paper
• Activation of phosphatidylinositol 3-kinase contributes to insulin-like growth factor I-mediated inhibition of pancreatic beta-cell death.

  2002cites this paper
• Insulin-like Growth Factor I Prevents Mannitol-induced Degradation of Focal Adhesion Kinase and Akt*

  2002cites this paper
• Functions of PI 3‐kinase in development of the nervous system

  2002cites this paper
• Role of the Schwann cell in diabetic neuropathy.

  2002cites this paper
• Interleukin-1 beta and interferon-gamma induce proliferation and apoptosis in cultured Schwann cells.

  2002cites this paper
• IGF‐I and microglia/macrophage proliferation in the ischemic mouse brain

  2002cites this paper
• Schwan nCel lCaveolin- 1Expression Increase sDurin gMyelinatio nand Decrease sAfte rAxotomy

  2002cites this paper
• Schwann cell caveolin‐1 expression increases during myelination and decreases after axotomy

  2002cites this paper
• Activation of Phosphatidylinositol 3-Kinase Contributes to Insulin-Like Growth Factor I-Mediated Inhibition of Pancreatic β-Cell Death

  2002cites this paper
• Apoptosis in diabetic neuropathy.

  2002cites this paper
• Sublytic C5b‐9‐stimulated Schwann cell survival through PI 3‐kinase‐mediated phosphorylation of BAD

  2001influential citation
• Insulin-Like Growth Factor-1 Reduces Postischemic White Matter Injury in Fetal Sheep

  2001cites this paper
• Insulin‐Like Growth Factor‐I and Over‐Expression of Bcl‐xL Prevent Glucose‐Mediated Apoptosis in Schwann Cells

  2001cites this paper
• Tumor necrosis factor(alpha) and insulin-like growth factor-I in the brain: is the whole greater than the sum of its parts?

  2001cites this paper